Protein kinase inhibitor containing pyrrolopyridazine derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9815840
SERIAL NO

14916177

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WELLMARKER BIO CO LTD7TH FLOOR 155 SONGPA-DAERO SONGPA-GU SEOUL 05855 05855

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baik, Tae Gon Gyeonggi-do, KR 2 0
Hong, Eun Mi Gyeonggi-do, KR 1 0
Ji, Seung Hee Seoul, KR 3 1
Jung, Su Yeon Gyeonggi-do, KR 1 0
Jung, Won-Hyuk Gyeonggi-do, KR 6 6
Ki, So Young Gyeongsangnam-do, KR 4 3
Kim, Min Cheol Gyeonggi-do, KR 42 135
Kim, Seung Chan Gyeonggi-do, KR 9 10
Kim, Seung In Daejeon, KR 2 1
Lee, Eun Young Seoul, KR 100 1174
Park, Sook Kyung Seoul, KR 6 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00